|
summary: People vary in their response to interferon and glatiramer, first-line treatments used in MS. The authors found that switching treatments can be useful in people who have an initial poor response.
authors: Gajofatto A, Bacchetti P, Grimes B, High A, Waubant E
source: Mult Scler. 2008 Nov 21. [Epub ahead of print]
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Disease-modifyin
Glatiramer
Interferon
Multiple sclerosis
Relapsing/remitting MS
Sclerosis
|
